AstraZeneca warns German reforms could push pharma launches and investment out of Europe EU Reporter 3d
GSK doubles down on oncology as AstraZeneca’s pipeline cranks up Investors Chronicle 2d Article paywall
AstraZeneca launches Lokelma in Korea to prevent drop-off from key heart and kidney drugs Korea Biomedical Review 4d
AstraZeneca’s Ultomiris Hits Interim Phase III Endpoint In IgAN, Eyes Accelerated Filings Scrip Pharma Intelligence 5d
AstraZeneca's tozorakimab treble puts $5bn sales ceiling in sight, says Citi Proactive Investors (US) 5d